List of Chapters/Sections(Table Of Content)
1 Study Coverage
1.1 Rosiglitazone (CAS 122320-73-4) Product Introduction
1.2 Market by Type
1.2.1 Global Rosiglitazone (CAS 122320-73-4) Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Rosiglitazone Tablets
1.2.3 Rosiglitazone Maleate Tablets
1.2.4 Rosiglitazone Hydrochloride Tablets
1.2.5 Others
1.3 Market by Application
1.3.1 Global Rosiglitazone (CAS 122320-73-4) Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Rosiglitazone (CAS 122320-73-4) Sales Estimates and Forecasts 2017-2028
2.2 Global Rosiglitazone (CAS 122320-73-4) Revenue Estimates and Forecasts 2017-2028
2.3 Global Rosiglitazone (CAS 122320-73-4) Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Rosiglitazone (CAS 122320-73-4) Sales by Region
2.4.1 Global Rosiglitazone (CAS 122320-73-4) Sales by Region (2017-2022)
2.4.2 Global Sales Rosiglitazone (CAS 122320-73-4) by Region (2023-2028)
2.5 Global Rosiglitazone (CAS 122320-73-4) Revenue by Region
2.5.1 Global Rosiglitazone (CAS 122320-73-4) Revenue by Region (2017-2022)
2.5.2 Global Rosiglitazone (CAS 122320-73-4) Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Rosiglitazone (CAS 122320-73-4) Sales by Manufacturers
3.1.1 Global Top Rosiglitazone (CAS 122320-73-4) Manufacturers by Sales (2017-2022)
3.1.2 Global Rosiglitazone (CAS 122320-73-4) Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rosiglitazone (CAS 122320-73-4) in 2021
3.2 Global Rosiglitazone (CAS 122320-73-4) Revenue by Manufacturers
3.2.1 Global Rosiglitazone (CAS 122320-73-4) Revenue by Manufacturers (2017-2022)
3.2.2 Global Rosiglitazone (CAS 122320-73-4) Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Rosiglitazone (CAS 122320-73-4) Revenue in 2021
3.3 Global Rosiglitazone (CAS 122320-73-4) Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Rosiglitazone (CAS 122320-73-4) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Rosiglitazone (CAS 122320-73-4) Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Rosiglitazone (CAS 122320-73-4) Sales by Type
4.1.1 Global Rosiglitazone (CAS 122320-73-4) Historical Sales by Type (2017-2022)
4.1.2 Global Rosiglitazone (CAS 122320-73-4) Forecasted Sales by Type (2023-2028)
4.1.3 Global Rosiglitazone (CAS 122320-73-4) Sales Market Share by Type (2017-2028)
4.2 Global Rosiglitazone (CAS 122320-73-4) Revenue by Type
4.2.1 Global Rosiglitazone (CAS 122320-73-4) Historical Revenue by Type (2017-2022)
4.2.2 Global Rosiglitazone (CAS 122320-73-4) Forecasted Revenue by Type (2023-2028)
4.2.3 Global Rosiglitazone (CAS 122320-73-4) Revenue Market Share by Type (2017-2028)
4.3 Global Rosiglitazone (CAS 122320-73-4) Price by Type
4.3.1 Global Rosiglitazone (CAS 122320-73-4) Price by Type (2017-2022)
4.3.2 Global Rosiglitazone (CAS 122320-73-4) Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Rosiglitazone (CAS 122320-73-4) Sales by Application
5.1.1 Global Rosiglitazone (CAS 122320-73-4) Historical Sales by Application (2017-2022)
5.1.2 Global Rosiglitazone (CAS 122320-73-4) Forecasted Sales by Application (2023-2028)
5.1.3 Global Rosiglitazone (CAS 122320-73-4) Sales Market Share by Application (2017-2028)
5.2 Global Rosiglitazone (CAS 122320-73-4) Revenue by Application
5.2.1 Global Rosiglitazone (CAS 122320-73-4) Historical Revenue by Application (2017-2022)
5.2.2 Global Rosiglitazone (CAS 122320-73-4) Forecasted Revenue by Application (2023-2028)
5.2.3 Global Rosiglitazone (CAS 122320-73-4) Revenue Market Share by Application (2017-2028)
5.3 Global Rosiglitazone (CAS 122320-73-4) Price by Application
5.3.1 Global Rosiglitazone (CAS 122320-73-4) Price by Application (2017-2022)
5.3.2 Global Rosiglitazone (CAS 122320-73-4) Price Forecast by Application (2023-2028)
6 North America
6.1 North America Rosiglitazone (CAS 122320-73-4) Market Size by Type
6.1.1 North America Rosiglitazone (CAS 122320-73-4) Sales by Type (2017-2028)
6.1.2 North America Rosiglitazone (CAS 122320-73-4) Revenue by Type (2017-2028)
6.2 North America Rosiglitazone (CAS 122320-73-4) Market Size by Application
6.2.1 North America Rosiglitazone (CAS 122320-73-4) Sales by Application (2017-2028)
6.2.2 North America Rosiglitazone (CAS 122320-73-4) Revenue by Application (2017-2028)
6.3 North America Rosiglitazone (CAS 122320-73-4) Market Size by Country
6.3.1 North America Rosiglitazone (CAS 122320-73-4) Sales by Country (2017-2028)
6.3.2 North America Rosiglitazone (CAS 122320-73-4) Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Rosiglitazone (CAS 122320-73-4) Market Size by Type
7.1.1 Europe Rosiglitazone (CAS 122320-73-4) Sales by Type (2017-2028)
7.1.2 Europe Rosiglitazone (CAS 122320-73-4) Revenue by Type (2017-2028)
7.2 Europe Rosiglitazone (CAS 122320-73-4) Market Size by Application
7.2.1 Europe Rosiglitazone (CAS 122320-73-4) Sales by Application (2017-2028)
7.2.2 Europe Rosiglitazone (CAS 122320-73-4) Revenue by Application (2017-2028)
7.3 Europe Rosiglitazone (CAS 122320-73-4) Market Size by Country
7.3.1 Europe Rosiglitazone (CAS 122320-73-4) Sales by Country (2017-2028)
7.3.2 Europe Rosiglitazone (CAS 122320-73-4) Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Rosiglitazone (CAS 122320-73-4) Market Size by Type
8.1.1 Asia Pacific Rosiglitazone (CAS 122320-73-4) Sales by Type (2017-2028)
8.1.2 Asia Pacific Rosiglitazone (CAS 122320-73-4) Revenue by Type (2017-2028)
8.2 Asia Pacific Rosiglitazone (CAS 122320-73-4) Market Size by Application
8.2.1 Asia Pacific Rosiglitazone (CAS 122320-73-4) Sales by Application (2017-2028)
8.2.2 Asia Pacific Rosiglitazone (CAS 122320-73-4) Revenue by Application (2017-2028)
8.3 Asia Pacific Rosiglitazone (CAS 122320-73-4) Market Size by Region
8.3.1 Asia Pacific Rosiglitazone (CAS 122320-73-4) Sales by Region (2017-2028)
8.3.2 Asia Pacific Rosiglitazone (CAS 122320-73-4) Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Rosiglitazone (CAS 122320-73-4) Market Size by Type
9.1.1 Latin America Rosiglitazone (CAS 122320-73-4) Sales by Type (2017-2028)
9.1.2 Latin America Rosiglitazone (CAS 122320-73-4) Revenue by Type (2017-2028)
9.2 Latin America Rosiglitazone (CAS 122320-73-4) Market Size by Application
9.2.1 Latin America Rosiglitazone (CAS 122320-73-4) Sales by Application (2017-2028)
9.2.2 Latin America Rosiglitazone (CAS 122320-73-4) Revenue by Application (2017-2028)
9.3 Latin America Rosiglitazone (CAS 122320-73-4) Market Size by Country
9.3.1 Latin America Rosiglitazone (CAS 122320-73-4) Sales by Country (2017-2028)
9.3.2 Latin America Rosiglitazone (CAS 122320-73-4) Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Rosiglitazone (CAS 122320-73-4) Market Size by Type
10.1.1 Middle East and Africa Rosiglitazone (CAS 122320-73-4) Sales by Type (2017-2028)
10.1.2 Middle East and Africa Rosiglitazone (CAS 122320-73-4) Revenue by Type (2017-2028)
10.2 Middle East and Africa Rosiglitazone (CAS 122320-73-4) Market Size by Application
10.2.1 Middle East and Africa Rosiglitazone (CAS 122320-73-4) Sales by Application (2017-2028)
10.2.2 Middle East and Africa Rosiglitazone (CAS 122320-73-4) Revenue by Application (2017-2028)
10.3 Middle East and Africa Rosiglitazone (CAS 122320-73-4) Market Size by Country
10.3.1 Middle East and Africa Rosiglitazone (CAS 122320-73-4) Sales by Country (2017-2028)
10.3.2 Middle East and Africa Rosiglitazone (CAS 122320-73-4) Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Hengrui Pharma
11.1.1 Hengrui Pharma Corporation Information
11.1.2 Hengrui Pharma Overview
11.1.3 Hengrui Pharma Rosiglitazone (CAS 122320-73-4) Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Hengrui Pharma Rosiglitazone (CAS 122320-73-4) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Hengrui Pharma Recent Developments
11.2 GSK
11.2.1 GSK Corporation Information
11.2.2 GSK Overview
11.2.3 GSK Rosiglitazone (CAS 122320-73-4) Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 GSK Rosiglitazone (CAS 122320-73-4) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 GSK Recent Developments
11.3 Taiji Group
11.3.1 Taiji Group Corporation Information
11.3.2 Taiji Group Overview
11.3.3 Taiji Group Rosiglitazone (CAS 122320-73-4) Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Taiji Group Rosiglitazone (CAS 122320-73-4) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Taiji Group Recent Developments
11.4 Shengjitang Pharma
11.4.1 Shengjitang Pharma Corporation Information
11.4.2 Shengjitang Pharma Overview
11.4.3 Shengjitang Pharma Rosiglitazone (CAS 122320-73-4) Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Shengjitang Pharma Rosiglitazone (CAS 122320-73-4) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Shengjitang Pharma Recent Developments
11.5 Huanghe Pharma
11.5.1 Huanghe Pharma Corporation Information
11.5.2 Huanghe Pharma Overview
11.5.3 Huanghe Pharma Rosiglitazone (CAS 122320-73-4) Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Huanghe Pharma Rosiglitazone (CAS 122320-73-4) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Huanghe Pharma Recent Developments
11.6 Wanma Pharma
11.6.1 Wanma Pharma Corporation Information
11.6.2 Wanma Pharma Overview
11.6.3 Wanma Pharma Rosiglitazone (CAS 122320-73-4) Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Wanma Pharma Rosiglitazone (CAS 122320-73-4) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Wanma Pharma Recent Developments
11.7 Jingxin Pharma
11.7.1 Jingxin Pharma Corporation Information
11.7.2 Jingxin Pharma Overview
11.7.3 Jingxin Pharma Rosiglitazone (CAS 122320-73-4) Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Jingxin Pharma Rosiglitazone (CAS 122320-73-4) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Jingxin Pharma Recent Developments
11.8 STADA
11.8.1 STADA Corporation Information
11.8.2 STADA Overview
11.8.3 STADA Rosiglitazone (CAS 122320-73-4) Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 STADA Rosiglitazone (CAS 122320-73-4) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 STADA Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Rosiglitazone (CAS 122320-73-4) Industry Chain Analysis
12.2 Rosiglitazone (CAS 122320-73-4) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rosiglitazone (CAS 122320-73-4) Production Mode & Process
12.4 Rosiglitazone (CAS 122320-73-4) Sales and Marketing
12.4.1 Rosiglitazone (CAS 122320-73-4) Sales Channels
12.4.2 Rosiglitazone (CAS 122320-73-4) Distributors
12.5 Rosiglitazone (CAS 122320-73-4) Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Rosiglitazone (CAS 122320-73-4) Industry Trends
13.2 Rosiglitazone (CAS 122320-73-4) Market Drivers
13.3 Rosiglitazone (CAS 122320-73-4) Market Challenges
13.4 Rosiglitazone (CAS 122320-73-4) Market Restraints
14 Key Findings in The Global Rosiglitazone (CAS 122320-73-4) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
